Ibrutinib and rituximab induced rapid response in refractory Richter syndrome

E-ISSN： 2050-0904|3|7|615-617

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.3, Iss.7, 2015-07, pp. : 615-617

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carboxyhemoglobin in pediatric sepsis and the systemic inflammatory response syndrome

By Shahin A A Tamburro R F Schmidt J E

Clinical Intensive Care, Vol. 11, Iss. 6, 2000-12 ,pp. : 311-317

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion

Clinical Case Reports, Vol. 3, Iss. 7, 2015-07 ,pp. : 646-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab: In Rheumatoid Arthritis

By Frampton James E. Scott Lesley J.

BioDrugs, Vol. 21, Iss. 5, 2007-01 ,pp. : 333-341

Adis International

Access to resources Recommend Favorite

Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

By Fritsch P.O. Sidoroff A.

American Journal of Clinical Dermatology, Vol. 1, Iss. 6, 2000-11 ,pp. : 349-360

Adis International

Access to resources Recommend Favorite

Intravenous Immunoglobulin-Induced, Non-Eczematous, Vesiculobullous Eruptions in Stevens-Johnson Syndrome

By Lin Wan-Lung

American Journal of Clinical Dermatology, Vol. 10, Iss. 5, 2009-10 ,pp. : 339-342

Adis International

Access to resources Recommend Favorite